The prevalence and epidemiology of genetic renal disease amongst adults with chronic kidney disease in Australia

Abstract

BackgroundThere are an established and growing number of Mendelian genetic causes for chronic kidney disease (CKD) in adults, though estimates of prevalence have been speculative. The CKD Queensland (CKD.QLD) registry enables partial clarification of this through the study of adults with CKD receiving nephrology care throughout Queensland, Australia.MethodsData from the first 2,935 patients consented to the CKD.QLD registry across five sites was analysed, with a comparison between those with and without Genetic Renal Disease (GRD). Prevalence of GRD amongst those with diagnosed CKD, the general population, and commencing renal replacement therapy (RRT) was calculated using the CKD.QLD registry, national census data and extracted Australian and New Zealand Dialysis and Transplantation (ANZDATA) registry report data respectively.ResultsPatients with GRD constituted 9.8% of this Australian adult CKD cohort (287/2935). This was lower than in local incident RRT cohorts (2006–2011: 9.8% vs 11.3%, x2 = 0.014). Cases of adult CKD GRD were more likely to be female (54.0% vs 45.6%; x2 = 0.007), younger (mean 52.6 yrs vs 69.3 yrs, p < 0.001), have a higher eGFR (mean 49.7 ml/min/1.73 m2 vs 40.4 ml/min/1.73 m2, p < 0.001), and have earlier stage renal disease (CKD Stage 1: 15.7% vs 5.1%, x2 < 0.0005) than those without GRD.ConclusionsThe proportion of GRD amongst an Australian adult CKD population in specialty renal practice is similar to past estimations. GRD is a significant cause for CKD and for RRT commencement, presenting opportunities for ongoing longitudinal study, directed therapeutics and clinical service redesign.

Autosomal Tubulointerstitial Kidney Disease—MUC1 Type: Differential Proteomics Suggests that Mutated MUC1 (insC) Affects Vesicular Transport in Renal Epithelial Cells

“…New technologies of massive parallel sequencing and improvements in bioinformatics have brought remarkable progress to the identification of causative genes within the last years . It has also been estimated that at least 10% of adult patients in need of renal replacement therapy suffer from genetic disease . However, diagnostic markers and knowledge on the underlying pathomechanisms are frequently lacking in RKD.…”

KHA‐CARI guideline recommendations for the diagnosis and management of autosomal dominant polycystic kidney disease

“…Its well‐known characteristic phenotype is the development of numerous bilateral renal cysts that grow at an exponential rate through adult life and compress normal renal tissue, resulting in at least a 50% risk of end‐stage kidney disease (ESKD). In developed countries, ADPKD constitutes ~5–10% of dialysis populations . Heterozygous germ‐line mutations, predominantly in the PKD1 gene (85% of cases) or to a lesser extent in the PKD2 gene (15% of cases), cause ADPKD and are identified in up to 90% of patients.…”

A multidisciplinary renal genetics clinic improves patient diagnosis

“…Multidisciplinary clinics are proposed to overcome this 1 in many medical fields 2 . This is especially so in nephrology, which is typified by significant community disease burden 3 and heritability 4 . Several renal genetics clinics (RGCs) operate overseas, although their models and outcomes are largely unreported.…”